We are a biotechnology company developing precision IL-2/15 therapies for cancer

About Us

Twain Therapeutics is a biotechnology company developing precision IL-2/15 therapies for cancer. The company was founded using core strategies development by Cheng I Wang and John E Connolly. Our current team consist of:

John Connolly, PhD

Scientific Co-Founder

Cheng-I Wang, PhD

Scientific Co-Founder

Anna-Marie Fairhurst, PhD

Chief Operations Officer

Guy Heathers, PhD

VP Business Development